Randomized phase III trial of irinotecan plus cisplatin compared with paclitaxel plus carboplatin as first-line chemotherapy for ovarian clear cell carcinoma: JGOG3017/GCIG trial

Toru Sugiyama, Aikou Okamoto, Takayuki Enomoto, Tetsutaro Hamano, Eriko Aotani, Yasuhisa Terao, Nao Suzuki, Mikio Mikami, Nobuo Yaegashi, Kiyoko Kato, Hiroyuki Yoshikawa, Yoshihito Yokoyama, Hiroshi Tanabe, Koji Nishino, Hiroyuki Nomura, Jae Weon Kim, Byoung Gie Kim, Sandro Pignata, Jerome Alexandre, John GreenSeiji Isonishi, Fumitoshi Terauchi, Keiichi Fujiwara, Daisuke Aoki

Research output: Contribution to journalArticlepeer-review

67 Citations (Scopus)

Fingerprint Dive into the research topics of 'Randomized phase III trial of irinotecan plus cisplatin compared with paclitaxel plus carboplatin as first-line chemotherapy for ovarian clear cell carcinoma: JGOG3017/GCIG trial'. Together they form a unique fingerprint.

Medicine & Life Sciences